Baxter has three manufacturing facilities in Puerto Rico, all of which are operating on limited manufacturing capacity. As a result, many U.S. hospitals are experiencing shortages of Baxter’s IV products.
Baxter CEO José Almeida told analysts the company should achieve normal inventory levels for affected products — and see little financial impact from the supply chain disruptions — by the first quarter of 2018, according to Reuters.
More articles on supply chain:
FDA OKs expanded use for Alexion’s ultra-rare disease drug
Survey: 61% of patient advocacy groups have favorable view of devicemakers
Hospitals grapple with medical supply shortages in wake of Hurricane Maria: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
